SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2202Because it’s 100% synthetic, Copaxone is much easier than Lovenox to reverse engDewDiligence_on_SI-3/14/2010
2201>>Copaxone Markman hearing. Dew - Do you have a view on the relative scBiomaven-3/14/2010
2200<i>>…I probably wouldn't give them much credit for the other prograDewDiligence_on_SI-3/14/2010
2199$5-6 sounds reasonable. Even though, at this point, I probably wouldn't giverkrw-3/14/2010
2198"lovenox downside risk?" I obviously don't know. Since there havRocky9-3/14/2010
2197What are you factoring in for the downside risk of a Lovenox setback? Obviouslrkrw-3/14/2010
2196I second that. If only I had held some of the shares I was forced to own. JoRobohogs-3/13/2010
2195No more questions. I now fully understand what you've been doing and why yoIan@SI-3/12/2010
2194"Have you been selling Puts or Calls." Selling puts mostly. In the fRocky933/12/2010
2193siliconinvestor.com provides some context and hyperlinks for the description of DewDiligence_on_SI-3/12/2010
2192This is new insofar as it is now in writing, but it merely confirms what WheelerDewDiligence_on_SI-3/12/2010
2191Have you been selling Puts or Calls. If you've been selling PUTs your shareIan@SI-3/12/2010
2190re options: I have been selling very term puts for a couple years now. The volRocky9-3/12/2010
2189From the 10K. I'm not sure this has been detailed before. M402 rkrw-3/12/2010
2188Noticing on IHub some general observations about Momenta options. That they aretuck-3/11/2010
2187Jeez Dew you're a bio guru here too? any other good boards you can reco?*Tina*-3/7/2010
2186I replied re Peptimmune in siliconinvestor.com . Regards, DewDewDiligence_on_SI-3/5/2010
2185Is this the "gentleman" responsible for the delays MNTA has seen? I hIan@SI-3/5/2010
2184Jim, would you be kind enough to repost that on iHub? I may want to add it to thDewDiligence_on_SI-3/5/2010
2183Copaxone competition. Press Release Source: Peptimmune, Inc. On Friday March 5,rkrw-3/5/2010
2182Thanks for the explanation and the link.Ian@SI-3/4/2010
2181In this trial, Apixaban was statsig superior to Lovenox in efficacy and was numeDewDiligence_on_SI-3/4/2010
2180Can you explain to me what's the difference between Statistically SUPERIOUR Ian@SI-3/4/2010
2179MNTA ‘ReadMeFirst’ updated: <i>the sorry state of Amphastar’s ANDA (from DewDiligence_on_SI-2/26/2010
2178China has a lot of room for improvement when it comes to protecting foreign drugDewDiligence_on_SI-2/16/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News